Abstract
Caffeine and aspirin have been suggested to be involved in neurologic diseases, such as schizophrenia, and previous data have revealed that abnormal expression of HERV-W elements may be an important factor in the etiopathogenesis of those diseases. In this article, we reported that caffeine and aspirin contributed to the expression of HERV-W env and gag in Human SH-SY5Y neuroblastoma cells. Semi-quantitative RT-PCR and quantitative Real-time PCR were used to detect the mRNA of HERV-W env and gag in cells exposed to caffeine or aspirin. Western blotting was used to detect the protein of HERV-W env. Luciferase activity assay was employed to detect the activity of HERV-W env promoter. It was found that both caffeine and aspirin could increase the expression of HERV-W env and gag in human SH-SY5Y neuroblastoma cells. Caffeine could activate the HERV-W env promoter, while aspirin could not. With previous studies we can conjecture that HERVs might play a bridging role between environmental factors, such as drugs and neurologic diseases.
Similar content being viewed by others
References
R. Belshaw, V. Pereira, A. Katzourakis, G. Talbot, J. Paces, A. Burt, M. Tristem, Proc. Natl. Acad. Sci. USA. 101, 4894–4899 (2004)
R. Belshaw, A. Katzourakis, J. Paces, A. Burt, M. Tristem, Mol. Biol. Evol. 22, 814–817 (2005)
N. Bannert, R. Kurth, Proc. Natl. Acad. Sci. USA. 101(Suppl 2), 14572–14579 (2004)
D. J. Griffiths, Genome Biol., 2 (2001) REVIEWS1017
S. Mi, X. Lee, X. Li, G.M. Veldman, H. Finnerty, L. Racie, E. LaVallie, X.Y. Tang, P. Edouard, S. Howes, J.C. Keith Jr, J.M. McCoy, Nature. 403, 785–789 (2000)
M. Mangeney, N. de Parseval, G. Thomas, T. Heidmann, J. Gen. Virol. 82, 2515–2518 (2001)
P.E. Kowalski, D.L. Mager, J. Virol. 72, 6164–6168 (1998)
J.L. Blond, F. Beseme, L. Duret, O. Bouton, F. Bedin, H. Perron, B. Mandrand, F. Mallet, J. Virol. 73, 1175–1185 (1999)
F. Mallet, O. Bouton, S. Prudhomme, V. Cheynet, G. Oriol, B. Bonnaud, G. Lucotte, L. Duret, B. Mandrand, Proc. Natl. Acad. Sci. USA. 101, 1731–1736 (2004)
H. Perron, J.A. Garson, F. Bedin, F. Beseme, G. Paranhos-Baccala, F. Komurian-Pradel, F. Mallet, P.W. Tuke, C. Voisset, J.L. Blond, B. Lalande, J.M. Seigneurin, B. Mandrand, Proc. Natl. Acad. Sci. USA. 94, 7583–7588 (1997)
J. Clausen, Int. Ms J. 10, 22–28 (2003)
S. Sotgiu, G. Mameli, C. Serra, I.R. Zarbo, G. Arru, A. Dolei, Mult. Scler. 16, 1248–1251 (2010)
O. Frank, M. Giehl, C. Zheng, R. Hehlmann, C. Leib-Mosch, W. Seifarth, J. Virol. 79, 10890–10901 (2005)
H. Karlsson, S. Bachmann, J. Schroder, J. McArthur, E.F. Torrey, R.H. Yolken, Proc. Natl. Acad. Sci. USA. 98, 4634–4639 (2001)
H. Karlsson, J. Schroder, S. Bachmann, C. Bottmer, R.H. Yolken, Mol. Psychiatry. 9, 12–13 (2004)
W.J. Huang, Z.C. Liu, W. Wei, G.H. Wang, J.G. Wu, F. Zhu, Schizophr. Res. 83, 193–199 (2006)
W. Huang, S. Li, Y. Hu, H. Yu, F. Luo, Q. Zhang, F. Zhu, Schizophr. Bull. 37, 988–1000 (2011)
H. Perron, L. Mekaoui, C. Bernard, F. Veas, I. Stefas, M. Leboyer, Biol. Psychiatry. 64, 1019–1023 (2008)
U. Schon, W. Seifarth, C. Baust, C. Hohenadl, V. Erfle, C. Leib-Mosch, Virology. 279, 280–291 (2001)
Y. Stauffer, G. Theiler, P. Sperisen, Y. Lebedev, C.V. Jongeneel, Cancer Immun. 4(2), 2 (2004)
W. Seifarth, O. Frank, U. Zeilfelder, B. Spiess, A.D. Greenwood, R. Hehlmann, C. Leib-Mosch, J. Virol. 79, 341–352 (2005)
K. Buscher, U. Trefzer, M. Hofmann, W. Sterry, R. Kurth, J. Denner, Cancer Res. 65, 4172–4180 (2005)
Q.Y. Liang, Z.F. Xu, R.Z. Xu, S. Zheng, J.Y. Ding, Ai. Zheng. 26, 952–956 (2007)
P.N. Nelson, A.M. Lever, S. Smith, R. Pitman, P. Murray, S.A. Perera, O.M. Westwood, F.C. Hay, H.D. Ejtehadi, J.C. Booth, Immunol. Invest. 28, 277–289 (1999)
F.C. Hsiao, M. Lin, A. Tai, G. Chen, B.T. Huber, J. Immunol. 177, 2056–2060 (2006)
C. Nellaker, Y. Yao, L. Jones-Brando, F. Mallet, R.H. Yolken, H. Karlsson, Retrovirology. 3(44), 44 (2006)
O. Frank, L. Jones-Brando, C. Leib-Mosch, R. Yolken, W. Seifarth, J. Infect. Dis. 194, 1447–1449 (2006)
C. Hohenadl, H. Germaier, M. Walchner, M. Hagenhofer, M. Herrmann, M. Sturzl, P. Kind, R. Hehlmann, V. Erfle, C. Leib-Mosch, J. Invest Dermatol. 113, 587–594 (1999)
J.I. Benson, J.J. David, Am. J. Psychiatry. 143, 940–941 (1986)
M. Rihs, C. Muller, P. Baumann, Eur. Arch. Psychiatry Clin. Neurosci. 246, 83–92 (1996)
M. Strassnig, J.S. Brar, R. Ganguli, Schizophr. Res. 86, 269–275 (2006)
D.C. Henderson, C.P. Borba, T.B. Daley, R. Boxill, D.D. Nguyen, M.A. Culhane, P. Louie, C. Cather, E.A. Eden, O. Freudenreich, S.M. Taber, D.C. Goff, Ann. Clin. Psychiatry. 18, 99–105 (2006)
M.O. Zaslove, R.L. Russell, E. Ross, Br. J. Psychiatry. 159(565–7), 565–567 (1991)
D.C. Goff, D.C. Henderson, E. Amico, Am. J. Psychiatry. 149, 1189–1194 (1992)
J. Kurebayashi, T. Otsuki, H. Kunisue, K. Tanaka, S. Yamamoto, H. Sonoo, Clin. Cancer Res. 6, 512–518 (2000)
W. Zwart, A. Griekspoor, V. Berno, K. Lakeman, K. Jalink, M. Mancini, J. Neefjes, R. Michalides, EMBO J. 26, 3534–3544 (2007)
S. Prudhomme, G. Oriol, F. Mallet, J. Virol. 78, 12157–12168 (2004)
J.M. Yi, H.M. Kim, H.S. Kim, J. Gen. Virol. 85, 1203–1210 (2004)
K. Yao, M. Mandel, N. Akyani, K. Maynard, N. Sengamalay, J. Fotheringham, E. Ghedin, F. Kashanchi, S. Jacobson, Glia. 53, 789–798 (2006)
R. Mancuso, S. Delbue, E. Borghi, E. Pagani, M.G. Calvo, D. Caputo, E. Granieri, P. Ferrante, J. Med. Virol. 79, 192–199 (2007)
K. Ruprecht, K. Obojes, V. Wengel, F. Gronen, K.S. Kim, H. Perron, J. Schneider-Schaulies, P. Rieckmann, J. Neurovirol. 12, 65–71 (2006)
R.M. Sandri-Goldin, Infect. Agents Dis. 3, 59–67 (1994)
B.B. Fredholm, K. Battig, J. Holmen, A. Nehlig, E.E. Zvartau, Pharmacol. Rev. 51, 83–133 (1999)
R. Lovett, New Scientist, 2518 (2005)
U. D. o. A. U. Food Survey Research Group, 1994–1996 and 1998 Continuing Survey of Food Intakes by Individuals, 2000
E.K. Tan, Z.Y. Lu, S.M. Fook-Chong, E. Tan, H. Shen, E. Chua, Y. Yih, Y.Y. Teo, Y. Zhao, Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 634–636 (2006)
M. Kitagawa, H. Houzen, K. Tashiro, Mov. Disord. 22, 710–712 (2007)
M.W. Vernooij, M.D. Haag, A. van der Lugt, A. Hofman, G.P. Krestin, B.H. Stricker, M.M. Breteler, Arch. Neurol. 66, 714–720 (2009)
P.B. Gorelick, Arch. Neurol. 66, 691–693 (2009)
S. Macdonald, BMJ. 325, 988 (2002)
M.J. Guitton, J. Caston, J. Ruel, R.M. Johnson, R. Pujol, J.L. Puel, J. Neurosci. 23, 3944–3952 (2003)
Acknowledgments
This work was supported by Grants from the National Natural Sciences Foundation of China (No. 81271820, No. 30870789, and No. 30300117), Stanley Foundation from the Stanley Medical Research Institute (SMRI), USA (No. 06R-1366) for Dr. F Zhu, Hubei Provincial Natural Science Foundation for Innovative Research Team (No. 2012FFA043), and the project of Innovative Research Team of Wuhan University (No. 274041).
Author information
Authors and Affiliations
Corresponding author
Additional information
Chunlan Liu and Yatang Chen contributed equally to this study.
Rights and permissions
About this article
Cite this article
Liu, C., Chen, Y., Li, S. et al. Activation of elements in HERV-W family by caffeine and aspirin. Virus Genes 47, 219–227 (2013). https://doi.org/10.1007/s11262-013-0939-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11262-013-0939-6